Optimization of Standard Treatment in AML
In session II of iwAL 2019, Adriano Venditti, MD,
Bob Löwenberg, MD, PhD and Richard Larson, MD, present risk-adapted therapies for primary AML based on genetics and MRD, frontline treatments in AML and treatment and outcomes of AML in older patients.
The University of Chicago Medicine, Chicago, IL
University of Rome Tor Vergata, Rome, Italy
Erasmus University Medical Center, Rotterdam, The Netherlands